Imperial Brands Talks About Tobacco Harm Reduction

Posted 31st March 2021 by Dave Cross
Imperial Brands attended this year’s Endoprothetik-Congress for the first time, through its Reemtsma Germany subsidiary. The annual event is hosted by the Charité Berlin and was moved online this year due to Covid-19 restrictions. Senior Cluster Officer, Scientific And Regulatory Affairs Dach & Nordics, Dr Thomas Nahde reports on the virtual event.

The Endoprothetik-Congress is an annual platform for around 400-500 surgeons, ranging from top key opinion leaders in orthopaedic surgery to early-career professionals and physiotherapists. The event encourages exchange of medical and scientific knowledge on a broad range of subjects, focusing on knee and hip arthroplasty, but include other orthopaedic topics such as post-operatic complication management and prevention. These latter topics are where Tobacco Harm Reduction (THR) is relevant, because patient smoking of combustible cigarettes after procedures can affect recovery.

As Imperial Brands’ Scientific Affairs and Engagement Representative, I manned a virtual stand throughout the event, outlining the public health policy of harm reduction and the role of Tobacco Harm Reduction (THR) science in the development of our Next Generation Products (NGPs). I also covered the role of nicotine when decoupled from burned tobacco in the context of THR.

I also had the opportunity to present a live lecture ‘Risk Reduction by Alternatives for Smoking’ in front of 400 attendees during the main scientific programme session for ‘Complication Prevention in Knee and Hip Arthroplasty’. Here, I introduced THR in the context that a) smoking may be an important risk factor for surgical complications, and b) physicians very often have significant misunderstandings around nicotine and its perceived role in smoking-related diseases.

The short lecture landed very well and started first thoughts and conversations with Professor Thorsten Gehrke (one of the two chairmen during the session and Director of the Helios-Endo-Clinic in Hamburg) confessing: “I really learned something from your lecture today — until today I also believed that nicotine is mainly responsible for smoking related diseases.”

Prof. Gehrke is also one of the three Congress Presidents, and he added that the THR presentation was technically excellent and economically balanced and received extremely positively by the vast majority of his colleagues.


The Endo-Congress organisers report at least 900 attendees; from these around 400 attended the session on risk management with the lecture on THR.

To continue on this path of medical and scientific education around THR, further activities for healthcare providers including orthopedy, dentistry as well as wound management are now planned for the future, further educating influential medical professionals about nicotine and the potential public health benefit potential of endorsing THR strategies.

Content was supplied by Imperial Brands under a Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) license. It has been published here as we feel it is important to listen to all parties involved in tobacco harm reduction.

Image supplied by Imperial Brands Science

 Dave Cross
Article by Dave Cross
Freelance writer, physicist, karateka, motorbikes, and dog walker